Medication info
Pharmgen Ciprofloxacin Tablet 250mg (Ciprofloxacin Hydrochloride)

Pharmgen Ciprofloxacin Tablet 250mg (Ciprofloxacin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Ciprofloxacin Hydrochloride›291mg / 1 tablet
Manufacturer / importer
Pharmgen Science Co., Ltd.
Appearance
White to yellowish round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201801715 · Approved 2018.04.23 · Insurance code 670104220

Summary

Main use
Treatment of infections of the genitourinary tract, respiratory tract, ear, nose and throat, eyes, abdomen, skin, and osteoarticular system
Who takes it
Adults
Adult dose
○ Usual adult dose: Administer 250 ~ 500 mg of ciprofloxacin orally twice daily between meals. For severe complicated infections, the dose of this drug may be increased to 750 mg per dose, twice daily. For acute infections, treatment is usually given for 5 ~ 10 days, and continued for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose, twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose, once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following equations. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) In severe infections, the dose per administration may be increased to 750 mg even in severe renal impairment; however, the patient's condition should be carefully monitored after administration. Adjust the dose appropriately according to symptoms.

Ingredients

Manufacturer
Pharmgen Science Co., Ltd.

Efficacy & effects

Treatment of infections of the genitourinary tract, respiratory tract, ear, nose and throat, eyes, abdomen, skin, and osteoarticular system

  • Acute bronchitis
  • respiratory infections
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • otitis externa
  • chronic cholesteatomatous otitis media
  • chronic otitis media
  • bacterial prostatitis
  • acute uncomplicated cystitis
  • acute pyelonephritis
View approved original text

This medication is used to treat various infections caused by different bacteria. It is effective against respiratory infections excluding acute bronchitis, community-acquired pneumonia, infections of the ear, nose, and throat, as well as bacterial prostatitis and urinary tract infections. It is also used for gonococcal cervicitis and urethritis, gastrointestinal and biliary tract infections, skin and soft tissue infections, and bone and joint infections. It is helpful in treating gynecological infections, peritonitis, and infections around the eyes. However, as a fluoroquinolone, it may pose risks for serious adverse reactions, and its use is recommended only when no other treatment options are available in specific situations. This drug is used to improve various bacterial infections.

How to take

Adult dose

○ Usual adult dose: Administer 250 ~ 500 mg of ciprofloxacin orally twice daily between meals. For severe complicated infections, the dose of this drug may be increased to 750 mg per dose, twice daily. For acute infections, treatment is usually given for 5 ~ 10 days, and continued for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose, twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose, once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following equations. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) In severe infections, the dose per administration may be increased to 750 mg even in severe renal impairment; however, the patient's condition should be carefully monitored after administration. Adjust the dose appropriately according to symptoms.

Precautions

This medication can cause severe side effects such as tendonitis, tendon rupture, peripheral neuropathy, and central nervous system disorders. If any of these symptoms occur, discontinue use immediately. Patients with myasthenia gravis should avoid taking this medication, as it may worsen their symptoms. Women who are pregnant or may become pregnant, nursing mothers, children under 18 years old, and patients with epilepsy should not use this medication. Patients with severely impaired kidney function, those with a history of seizures, elderly patients, and those with central nervous system disorders should use this medication with caution. Due to the risk of serious adverse reactions, any pain, sensory abnormalities, mental changes, or visual disturbances should be reported to a doctor immediately. Additionally, this medication may interact with specific drugs, increasing the risk of side effects, so inform healthcare professionals if you are taking any other medications. Photosensitivity reactions may occur, so avoid strong sunlight and ultraviolet exposure. If gastrointestinal symptoms such as diarrhea occur, discontinue use and seek medical attention. Patients with diabetes should monitor their blood sugar levels carefully, as this medication can affect blood glucose control. Overdose may increase the risk of kidney damage, so adhere to the prescribed dosage and duration. Store in a place out of reach of children and avoid direct sunlight.

Side effects

Tendonitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, decreased red blood cells, decreased hemoglobin, decreased hematocrit, agranulocytosis, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic edema, angioedema, anaphylactic reactions, anaphylactoid shock, serum sickness-like reactions, decreased appetite, decreased food intake, increased blood alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory disturbances, sensory loss, loss of taste, tremor, convulsions, vertigo, delirium, seizures, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, sensory hypersensitivity, increased intracranial pressure, ataxia, peripheral neuropathy, polyneuropathy, vision impairment, chromatopsia, diplopia, tinnitus, hearing loss, transient hearing loss, hearing impairment, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, anorexia, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, colitis with hematochezia, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, drug reaction with eosinophilia and systemic symptoms, fixed drug eruptions, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tension and cramps, joint swelling, muscle weakness, partial or complete tendon rupture, renal impairment, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undiagnosed pain, discomfort, fever, asthenia, edema, sweating, gait disorders, maculopapular rash, purpuric rash, injection site rash, injection site itching, injection site urticaria, aneurysm, aortic dissection, valvular insufficiency, valvular regurgitation, musculoskeletal disorders, psychiatric disorders, sensory disturbances, glucose disorders, hypoglycemia, shock, hypotension, chest tightness, rhabdomyolysis, muscle weakness, interstitial pneumonia, visual impairment, retinal detachment

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to avoid exposure to air or moisture. It is recommended to maintain the storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White to yellowish round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.